Title: Emerging mechanisms of enzalutamide resistance in prostate cancer
Authors: Claessens, Frank ×
Helsen, Christine
Prekovic, Stefan
Van den Broeck, Thomas
Spans, Lien
Van Poppel, Hendrik
Joniau, Steven #
Issue Date: Dec-2014
Series Title: Nature reviews. Urology vol:11 issue:12 pages:712-716
Article number: 10.1038/nrurol.2014.243
Abstract: The majority of prostate cancers are hormone-dependent at diagnosis highlighting the central role of androgen signalling in this disease. Surprisingly, most forms of castration-resistant prostate cancer (CRPC) are still dependent on the androgen receptor (AR) for survival. Therefore, the advent of new AR-targeting drugs, such as enzalutamide, is certainly beneficial for the many patients with metastatic CRPC. Indeed, this compound provides a substantial survival benefit-but it is not curative. This Perspectives article describes the different ways through which cancer cells can become resistant to enzalutamide, such as AR truncation and other mutations, as well as by-pass of the AR dependence of prostate cancer cells through expression of the glucocorticoid receptor. The clinical relevance of these mechanisms and emerging questions concerning new therapeutic regimens in the treatment of metastatic CRPC are being discussed.
ISSN: 1759-4812
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Organ Systems (+)
Laboratory of Molecular Endocrinology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science